Core Viewpoint - Bernstein Liebhard LLP is reminding investors of Vistagen Therapeutics, Inc. about a deadline related to a securities fraud class action lawsuit against the company [1]. Group 1: Lawsuit Details - A class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who purchased Vistagen common stock between April 1, 2024, and December 16, 2025, alleging violations of the Securities Exchange Act of 1934 [3]. - The lawsuit claims that the defendants made misrepresentations regarding the Company's Phase 3 PALISADE-3 trial study of fasedienol, which is being developed for the acute treatment of social anxiety disorder [4]. Group 2: Legal Participation - Investors wishing to serve as lead plaintiff for the class must file papers by March 16, 2026, with the role involving directing the litigation on behalf of other class members [5]. - Participation as a lead plaintiff is not required to share in any potential recovery, and all representation is on a contingency fee basis, meaning shareholders incur no fees or expenses [5]. Group 3: Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for its clients since 1993 and has represented both individual investors and large public and private pension funds [6]. - The firm has been recognized for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [6].

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Coupang, Inc. (NYSE: CPNG)? Did you purchase your shares between August 6, 2025 and December 16, 2025, inclusive? Did you lose money in your investment in Coupang, Inc.? Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Coupang, Inc. (“Coupang” or the “Company”) (NYSE: CPNG) investors of an upcoming deadline involving a securities fraud clas ...

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of CoreWeave, Inc. (NASDAQ: CRWV)? Did you purchase your shares between March 28, 2025 and December 15, 2025, inclusive? Did you lose money in your investment in CoreWeave, Inc.? Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds CoreWeave, Inc. (“CoreWeave” or the “Company”) (NASDAQ: CRWV) investors of an upcoming deadline involving a securitie ...

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE: BBWI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.            The class action concerns whether Bath & Bod ...

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. ("Aquestive" or the "Company") (NASDAQ: AQST).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Aquestive and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Ja ...

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation for allegedly making misleading statements and failing to disclose material adverse facts regarding its business performance during the specified Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who acquired Integer securities from July 25, 2024, to October 22, 2025 [1][2]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Allegations Against the Company - The complaint alleges that Integer overstated its competitive position and did not adequately disclose sales deterioration in its electrophysiology devices [3]. - The lawsuit claims that the company mischaracterized its growth drivers, leading to a significant decline in stock price following the revelation of these issues [3]. Group 3: Impact of Disclosures - On October 23, 2025, Integer reduced its sales guidance and disclosed an expected sales decline, resulting in a stock price drop of $35.22 per share, which is over 32% in a single trading day [3].

Core Viewpoint - A class action lawsuit has been filed against SLM Corporation (Sallie Mae) for allegedly concealing a significant increase in loan delinquencies during a specific period, leading to investor losses [1][3]. Group 1: Lawsuit Details - The lawsuit represents investors who acquired Sallie Mae securities from July 25, 2025, to August 14, 2025 [1]. - Investors have until February 17, 2026, to seek appointment as lead plaintiff representatives [2]. Group 2: Allegations - Sallie Mae is accused of hiding the true cause of rising early-stage delinquencies, which were reportedly increasing significantly despite the company's claims of normal seasonal fluctuations and effective loss mitigation programs [3]. - A TD Cowen report published on August 14, 2025, revealed that July delinquencies rose by 49 basis points month-over-month, exceeding seasonal expectations [4]. Group 3: Market Reaction - Following the revelation of the delinquency spike, Sallie Mae's stock price fell by $2.67 per share, or 8.09%, closing at $30.32 on August 15, 2025 [4].

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Varonis Systems, Inc. (NASDAQ: VRNS). Shareholders who purchased shares of VRNS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/varonis-systems-inc-loss-submission-form/?id=183201&from=4 CLASS PERIOD: Februa ...

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of CoreWeave, Inc. (NASDAQ: CRWV). Shareholders who purchased shares of CRWV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/coreweave-inc-loss-submission-form/?id=183204&from=4 CLASS PERIOD: March 28, 2025 to ...

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. Financial Performance and Stock Impact - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock price drop of $2.18 per share, or 6.9%, from $31.54 to $29.36 [6]. - Following the Q3 2025 financial results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock price fell by $5.22 per share, or 24.8%, from $21.04 to $15.82 [7]. Legal Proceedings - Investors have until March 16, 2026, to request to lead the case in the ongoing lawsuit, which is filed under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 in the U.S. District Court for the Southern District of Ohio [3].